REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Science Regulatory News (LABS)

Share Price Information for Life Science (LABS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.80
Bid: 39.80
Ask: 40.00
Change: -0.20 (-0.50%)
Spread: 0.20 (0.503%)
Open: 40.10
High: 40.10
Low: 39.80
Prev. Close: 40.00
LABS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Feb 2024 10:12

RNS Number : 9769C
Life Science REIT PLC
13 February 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BP5X4Q29

Issuer Name

LIFE SCIENCE REIT PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

Other

Comments

Hazelview Securities Inc. no longer having control or direction over a client's assets.

3. Details of person subject to the notification obligation

Name

Hazelview Investments Inc.

City of registered office (if applicable)

Toronto

Country of registered office (if applicable)

Canada

4. Details of the shareholder

Name

City of registered office

Country of registered office

Hazelview Securities (US) LLC

Toronto

Canada

Hazelview Securities Inc.

Toronto

Canada

5. Date on which the threshold was crossed or reached

31-Jan-2024

6. Date on which Issuer notified

12-Feb-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

1.080000

0.000000

1.080000

3784262

Position of previous notification (if applicable)

4.940000

0.000000

4.940000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BP5X4Q29

3784262

0

1.080000

0.000000

Sub Total 8.A

3784262

1.080000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Hazelview Investments Inc. (Chain 2)

Hazelview Securities (US) LLC (Subsidiary 2)

Hazelview Investments Inc. (Chain 1)

Hazelview Securities Inc. (Subsidiary 1)

10. In case of proxy voting

Name of the proxy holder

Hazelview Securities Inc. and Hazelview Securities (US) LLC on behalf of its client accounts.

The number and % of voting rights held

1.08

The date until which the voting rights will be held

Until the securities are sold.

11. Additional Information

12. Date of Completion

12-Feb-2024

13. Place Of Completion

Toronto, Ontario, Canada

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLGPUGGPUPCGUW
Date   Source Headline
8th May 20245:13 pmRNSHolding(s) in Company
7th May 20247:00 amRNSPurchase of Ordinary Shares by Investment Adviser
1st May 202410:24 amRNSHolding(s) in Company
30th Apr 20241:24 pmRNSHolding(s) in Company
26th Apr 20241:47 pmRNSHolding(s) in Company
25th Apr 20244:23 pmRNSHolding(s) in Company
25th Apr 20244:04 pmRNSNotice of AGM
27th Mar 20247:00 amRNSNew Agreement for Lease at Oxford Technology Park
26th Mar 20247:00 amRNSResults for the year ended 31 December 2023
14th Mar 20241:31 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSNotice of Full Year Results
13th Feb 202410:12 amRNSHolding(s) in Company
13th Feb 20247:00 amRNSNew Lease at OTP
17th Jan 20249:33 amRNSPurchase of Ordinary Shares by Investment Adviser
9th Jan 20245:29 pmRNSHolding(s) in Company
4th Jan 20247:00 amRNSNew Lease at Oxford Technology Park
14th Dec 20235:20 pmRNSHolding(s) in Company
13th Dec 20234:54 pmRNSHolding(s) in Company
12th Dec 20231:04 pmRNSHolding(s) in Company
4th Dec 20237:00 amRNSNew Lease at Oxford Technology Park
1st Dec 20237:00 amRNSSale of Lumen House, Harwell Oxford
24th Nov 20233:22 pmRNSHolding(s) in Company
23rd Nov 20234:21 pmRNSHolding(s) in Company
13th Nov 20232:21 pmRNSHolding(s) in Company
6th Nov 20235:38 pmRNSHolding(s) in Company
6th Nov 20235:26 pmRNSHolding(s) in Company
19th Oct 202311:20 amRNSHolding(s) in Company
11th Oct 202311:32 amRNSDirector Declaration
2nd Oct 20234:34 pmRNSHolding(s) in Company
25th Sep 202311:52 amRNSHolding(s) in Company
22nd Sep 20235:25 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSHalf Year Results
19th Sep 20231:54 pmRNSHolding(s) in Company
18th Sep 20235:44 pmRNSHolding(s) in Company
4th Sep 202311:29 amRNSHolding(s) in Company
29th Aug 20233:33 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSNotice of Half Year Results
21st Jul 20235:53 pmRNSHolding(s) in Company
4th Jul 202312:05 pmRNSHolding(s) in Company
27th Jun 20237:00 amRNSDebt Refinancing
25th May 20234:15 pmRNSResult of AGM
22nd May 20234:44 pmRNSHolding(s) in Company
15th May 20237:00 amRNSNew Lease at Cambourne Business Park
25th Apr 20237:00 amRNSPurchase of Ordinary Shares by Investment Adviser
17th Apr 20237:00 amRNSNotice of Capital Markets Day
4th Apr 202311:39 amRNSPublication of Supplementary Prospectus
27th Mar 20237:00 amRNSResults for the year ended 31 December 2022
23rd Mar 20237:00 amRNSPublication of Cell and Gene Therapy Report
3rd Mar 20237:00 amRNSAttractive Debt Refinancing
1st Mar 20232:34 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.